Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia (vol 152, pg 365, 2010)

被引：1
|
作者：
Suppressa, Patrizia
Liso, Arcangelo
Sabba, Carlo
机构：
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 154卷 / 01期
关键词：
D O I：
10.1111/j.1365-2141.2011.08767.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [1] Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab
    Wee, Jee Wan
    Jeon, Young Woo
    Eun, Jun Young
    Kim, Han Jo
    Bae, Sang Byung
    Lee, Kyu Taek
    BLOOD RESEARCH, 2014, 49 (03) : 192 - 195
  • [2] BEVACIZUMAB AS TREATMENT IN REFRACTORY HEREDITARY HAEMORRHAGIC TELANGIECTASIA
    Castillo, E.
    Prada-Arismendy, J.
    HAEMATOLOGICA, 2016, 101 : 408 - 408
  • [3] A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia
    C. Rohrmeier
    H. G. Sachs
    T. S. Kuehnel
    European Archives of Oto-Rhino-Laryngology, 2012, 269 : 531 - 536
  • [4] A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia
    Rohrmeier, C.
    Sachs, H. G.
    Kuehnel, T. S.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2012, 269 (02) : 531 - 536
  • [5] Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia
    Al-Samkari, H.
    Kritharis, A.
    Rodriguez-Lopez, J. M.
    Kuter, D. J.
    JOURNAL OF INTERNAL MEDICINE, 2019, 285 (02) : 223 - 231
  • [6] BEVACIZUMAB AS TREATMENT OF BLEEDING IN PATIENTS WITH HEREDITARY HAEMORRHAGIC TELANGIECTASIA (HHT)
    Kjeldsen, Jens
    Fialla, Annette D.
    Rosenberg, Tine
    Kjeldsen, Anette D.
    GASTROENTEROLOGY, 2018, 154 (06) : S701 - S702
  • [7] Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report
    Garcia-Martin, Estela
    Pernia-Lopez, Sagrario
    Martinez-Ortega, Pilar A.
    Monje, Beatriz
    Ruiz-Martinez, Cristina
    Sanjurjo-Saez, Maria
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2019, 26 (04) : 226 - 228
  • [8] The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab
    Alderman, Charles
    Corlett, Jonathan
    Cullis, Jonathan
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (04) : 547 - 548
  • [9] Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
    Thompson, Andrew B.
    Ross, Douglas A.
    Berard, Paul
    Figueroa-Bodine, Jaszmin
    Livada, Nancy
    Richer, Sara L.
    ALLERGY & RHINOLOGY, 2014, 5 (02): : E91 - E95
  • [10] Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia
    Cherif, Honar
    Karlsson, Torbjorn
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2014, 119 (04) : 350 - 353
12345